Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2008
12/09/2008US7462688 Peptides for diagnostic and therapeutic methods for celiac sprue
12/09/2008US7462607 Therapy-enhancing glucan
12/09/2008US7462479 Immunizing an avian with nonpathogenic immunogenically strain of Georgia 98 (GA-98) virus in attenuated or inactivated form; poultry vaccines
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/09/2008US7462359 Neospora vaccines
12/09/2008US7462358 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462356 Chimeric papillomavirus-like particles
12/09/2008US7462355 Angiogenesis regulation system
12/09/2008US7462354 Storing a plurality of input parameters in a memory of a computer system, generating a list of epitope pairs from epitopes; determining for each epitope pairs at least one optimum combination of amino acid insertions; identifying
12/09/2008US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
12/09/2008US7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
12/09/2008CA2215203C Vaccines for plague
12/09/2008CA2202504C Chimeric conformational epitope peptides
12/05/2008CA2631453A1 Glycoconjugates and their use as vaccine against shigella flexneri serotype 3a and x
12/05/2008CA2591253A1 Specific oligosaccharides of shigella flexneri serotypes 3a and x, their synthesis, compositions comprising them and their uses thereof
12/04/2008WO2008148057A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines
12/04/2008WO2008147956A2 Toll-like receptor 3 modulators and uses thereof
12/04/2008WO2008147883A1 Prevention and treatment of complement-associated eye conditions
12/04/2008WO2008147847A1 Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
12/04/2008WO2008147799A1 A live attenuated antigenically marked classical swine fever vaccine
12/04/2008WO2008147735A1 Identification of adaptive mutations that increase infectivity of hepatitis c virus jfh1 strain in cell culture
12/04/2008WO2008147526A1 Targeted carriers for intracellular drug delivery
12/04/2008WO2008147496A2 Neuraminidase-deficient live influenza vaccines
12/04/2008WO2008147489A1 Topical toll-like receptor ligands as vaccine adjuvants
12/04/2008WO2008147482A2 Methods and compositions for improving immune responses
12/04/2008WO2008147456A2 Drug delivery systems using fc fragments
12/04/2008WO2008147434A1 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN αVβ6
12/04/2008WO2008147187A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
12/04/2008WO2008146911A1 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
12/04/2008WO2008146841A1 Nucleic acid carrier for introduction of nucleic acid into cancer cell
12/04/2008WO2008146830A1 Bordetella parapertussis-containing whole-cell vaccine composition
12/04/2008WO2008146165A2 Kit of parts for the treatment of cancer or infectious diseases
12/04/2008WO2008146164A2 Streptococcus pneumoniae pilus antigens
12/04/2008WO2008146101A1 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008146003A1 Vaccine peptide combinations against cat allergy
12/04/2008WO2008145998A1 Vaccine peptide combinations against cat allergy
12/04/2008WO2008145866A1 Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease
12/04/2008WO2008145754A2 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008145745A1 Vaccine against hpv
12/04/2008WO2008145685A1 Hpv polyepitope constructs and uses thereof
12/04/2008WO2008145664A1 New indications for anti- il-i-beta therapy
12/04/2008WO2008145401A2 Mutated parvovirus structural proteins as vaccines
12/04/2008WO2008145338A2 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008WO2008145142A1 Stable igg4 antibodies
12/04/2008WO2008145138A1 Recombinant fucose modified monovalent half-antibodies obtained by molecular engineering
12/04/2008WO2008145129A2 Influenza vaccines
12/04/2008WO2008145074A2 Amino acid and nucleic acid sequences and vaccine to control ectoparasite infestations in fish
12/04/2008WO2008145021A1 A truncated l1 protein of human papillomavirus 6
12/04/2008WO2008145020A1 A truncated l1 protein of human papillomavirus 11
12/04/2008WO2008145000A1 A foot-and-mouth disease virus double-effective vaccine vector, construction method and uses thereof
12/04/2008WO2008144924A1 Immunogenic compositions comprising an agent capable of modulating a cd 1d-modulated pathway and methods of use
12/04/2008WO2008144919A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144889A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008127833A3 Enhancing efficacy of vaccines administered via the respiratory tract
12/04/2008WO2008127710A3 Methods for treating cancer resistant to erbb therapeutics
12/04/2008WO2008122551A3 Anti-epcam antibody and uses thereof
12/04/2008WO2008121881A3 INHIBITORS OF NF-ϰB ACTIVITY
12/04/2008WO2008121615A3 Antibody formulation
12/04/2008WO2008121127A3 Methods of use of polycomb homologue mel-18
12/04/2008WO2008120203A3 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
12/04/2008WO2008118936A3 Method of elicting immune response with a modified mva viral hiv-1 vector
12/04/2008WO2008116468A3 Mhc peptide complexes and uses thereof in infectious diseases
12/04/2008WO2008108980A3 Devices and methods for extracorporeal ablation of circulating cells
12/04/2008WO2008106393A3 Immunogenic compositions and methods for treating and preventing animal infections
12/04/2008WO2008104808A3 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair
12/04/2008WO2008103392A3 Modulation of nkt cell activity with antigen-loaded cdid molecules
12/04/2008WO2008094525A9 Detection of influenza virus
12/04/2008WO2008092095A3 Protein kinase c gamma as a biomarker for neuropsychological and cognitive functions in the central nervous system
12/04/2008WO2008091701A9 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
12/04/2008WO2008088902A3 Attenuation of the adaptive immune response
12/04/2008WO2008086813A3 Peptides derived from proteins of the insulin super-family
12/04/2008WO2008085987A9 Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display
12/04/2008WO2008079290A3 Stable buffered formulations containing polypeptides
12/04/2008WO2008076560A9 Human monoclonal antibodies to btla and methods of use
12/04/2008WO2008076257A3 Treating cancer with anti-igflr antibody 19d12 = sch 717454
12/04/2008WO2008070042A3 High potency recombinant antibodies, methods for producing them and use in cancer therapy
12/04/2008WO2008069999A3 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
12/04/2008WO2008067464A3 NEW Aβ CONFORMER SELECTIVE ANTI-Aβ GLOBULOMER MONOCLONAL ANTIBODIES
12/04/2008WO2008064292A3 Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof
12/04/2008WO2008063382A3 Antagonists of pcsk9
12/04/2008WO2008060645A3 Combinatorial therapy involving alpha5beta1 antagonists
12/04/2008WO2008057634A3 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
12/04/2008WO2008055703A3 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
12/04/2008WO2008042481A3 A method for the detection and neutralization of bacteria
12/04/2008WO2008039761A3 Stabilized antibody formulations and uses thereof
12/04/2008WO2008036867A3 Methods for treatment of inflammatory disease and chlamydia infectious disease
12/04/2008WO2008036675A3 Compositions and methods of enhancing immune responses
12/04/2008WO2008021076A3 Protein matrix vaccines and methods of making and administering such vaccines
12/04/2008WO2008011157A3 Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
12/04/2008WO2008005429A3 Composition for modulating the expression of cell adhesion molecules
12/04/2008WO2007136781A3 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance
12/04/2008WO2007114959A3 Altered peptide ligands of gad65
12/04/2008WO2007112410A3 Tolerizing agents
12/04/2008WO2007108992A3 Augmentation of endothelial thromboresistance
12/04/2008WO2007103261A3 Listeria-based epha2 immunogenic compositions
12/04/2008WO2007100628A3 Destruction of spores through glycoconjugate enhanced phagocytosis
12/04/2008WO2007097789A8 Attenuated francisella and methods of use
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 1823